(PharmaNewsWire.Com, June 01, 2017 ) Carbamazepine (CBZ) , sold under the tradename Tegretol among others, is a medication used primarily in the treatment of epilepsy and neuropathic pain. For seizures it works as well as phenytoin and valproate. It is not effective for absence seizures or myoclonic seizures. It may be used in schizophrenia along with other medications and as a second line agent in bipolar disorder.
This report provides detailed analysis of worldwide markets for Carbamazepine (CBZ) from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the volumes, prices, historical growth and future perspectives in the Carbamazepine (CBZ) market and further lays out an analysis of the factors influencing the supply/demand for Carbamazepine (CBZ) , and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.
The report has been prepared based on the synthesis, analysis, and interpretation of information about the global Carbamazepine (CBZ) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Carbamazepine (CBZ) market are TEVA (Israel) , TARO (Israel) , Jubilant Pharma (India) , Zhejiang Jiuzhou (China) , Jinan Jinda (China) , Sihuan Shengwu (China) , Jiangsu Tohope (China) , Shanghai Modern Hasen (China) etc.
The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Carbamazepine (CBZ) industry has been provided.
Table of Content: Part 1. Exclusive Summary Part 2. Methodology Part 3. Introduction Part 4. Market Landscape Part 5. Segmentation by Type Part 6. Segmentation by Application Part 7. North America Carbamazepine Market Part 8. Europe Carbamazepine Market Part 9. Asia Pacific Carbamazepine Market Part 10. Market Forecast Part 11. Company Profiles Part 12. Market Dynamics Part 13. Appendix
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
